Literature DB >> 10973879

Relationship of p16 methylation status and serum alpha-fetoprotein concentration in hepatocellular carcinoma patients.

I H Wong1, Y M Lo, P B Lai, P J Johnson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10973879

Source DB:  PubMed          Journal:  Clin Chem        ISSN： 0009-9147            Impact factor:   8.327


× No keyword cloud information.
  10 in total

1.  Evaluation of INK4A promoter methylation using pyrosequencing and circulating cell-free DNA from patients with hepatocellular carcinoma.

Authors:  Gengming Huang; Joseph D Krocker; Jason L Kirk; Shehzad N Merwat; Hyunsu Ju; Roger D Soloway; Lucas R Wieck; Albert Li; Anthony O Okorodudu; John R Petersen; Nihal E Abdulla; Andrea Duchini; Luca Cicalese; Cristiana Rastellini; Peter C Hu; Jianli Dong
Journal:  Clin Chem Lab Med       Date:  2014-06       Impact factor: 3.694

2.  The value of liquid biopsy in the diagnosis and staging of hepatocellular carcinoma: a systematic review.

Authors:  Poh Tan; Lisa Grundy; Peter Makary; Khem Hua Eng; George Ramsay; Mohamed Bekheit
Journal:  Transl Gastroenterol Hepatol       Date:  2021-10-25

3.  Specific mutations of hepatitis B virus in plasma predict liver cancer development.

Authors:  Shuang-Yuan Kuang; Peta E Jackson; Jin-Bing Wang; Pei-Xing Lu; Alvaro Muñoz; Geng-Sun Qian; Thomas W Kensler; John D Groopman
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-27       Impact factor: 11.205

Review 4.  New markers for cancer detection.

Authors:  Ivy H N Wong; Y M Dennis Lo
Journal:  Curr Oncol Rep       Date:  2002-11       Impact factor: 5.075

5.  High-throughput assessment of CpG site methylation for distinguishing between HCV-cirrhosis and HCV-associated hepatocellular carcinoma.

Authors:  Kellie J Archer; Valeria R Mas; Daniel G Maluf; Robert A Fisher
Journal:  Mol Genet Genomics       Date:  2010-02-18       Impact factor: 3.291

Review 6.  Nano-bio-technology and sensing chips: new systems for detection in personalized therapies and cell biology.

Authors:  Sandro Carrara
Journal:  Sensors (Basel)       Date:  2010-01-12       Impact factor: 3.576

7.  Value of quantitative and qualitative analyses of circulating cell-free DNA as diagnostic tools for hepatocellular carcinoma: a meta-analysis.

Authors:  Wenjun Liao; Yilei Mao; Penglei Ge; Huayu Yang; Haifeng Xu; Xin Lu; Xinting Sang; Shouxian Zhong
Journal:  Medicine (Baltimore)       Date:  2015-04       Impact factor: 1.889

Review 8.  The Mutational Landscape of Pancreatic and Liver Cancers, as Represented by Circulating Tumor DNA.

Authors:  Alistair Rice; Armando Del Rio Hernandez
Journal:  Front Oncol       Date:  2019-09-24       Impact factor: 6.244

9.  Usefulness of Circulating Methylated p16 as a Noninvasive Molecular Biomarker for Hepatitis C-Related Hepatocellular Carcinoma with Normal Serum Alpha-Fetoprotein Levels.

Authors:  Wael Abd Elgwad Elsewify; Elham Ahmed Hassan; Mohamed A Mekky; Abeer Sharaf El-Din Abd El-Rehim; Zain El-Abdeen Ahmed Sayed; Mohamed Omar Abdel Malek; Tarek T H ElMelegy; Abeer Sabry
Journal:  Int J Gen Med       Date:  2020-04-30

10.  Detection of aberrant p16INK4A methylation in sera of patients with liver cirrhosis and hepatocellular carcinoma.

Authors:  Hyung Jun Chu; Jeong Heo; Soo Boon Seo; Gwang Ha Kim; Dae Hwan Kang; Geun Am Song; Mong Cho; Ung Suk Yang
Journal:  J Korean Med Sci       Date:  2004-02       Impact factor: 2.153
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.